Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002351453 | SCV002645950 | uncertain significance | Cardiovascular phenotype | 2022-07-14 | criteria provided, single submitter | clinical testing | The c.5071C>T (p.R1691C) alteration is located in exon 14 (coding exon 13) of the TNXB gene. This alteration results from a C to T substitution at nucleotide position 5071, causing the arginine (R) at amino acid position 1691 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |